Challenging mass culture of mesenchymal stem cells: Soluble microcarriers A Three-Minute Guide: Applications of the ubiquitous collagen solution | Koken Co., Ltd.

AteloSeriesCollagen for Cell Culture and RNAi Techonology

Newsletters

Challenging mass culture of mesenchymal stem cells: Soluble microcarriers

22 July 2025

 

   

 

Challenging mass culture of mesenchymal stem cells: Soluble microcarriers

― Made from raw materials that conform to the Standards for Biological Raw Materials -

At the congress of the Japanese Society for Regenerative Medicine held in March this year, we received many inquiries regarding the mass culture of mesenchymal stem cells, which indicated the increasing research toward the clinical application of regenerative medicine. However, many researchers struggle with the removal of microcarriers after mass culture.

 

In this newsletter, the dissolution of soluble “Atelocollagen Microspheres” was introduced.

 

Removal of microcarriers

When mass culturing with microcarriers made of resin, cells must be harvested by filtration after culture. However, removing small debris that is generated during culture is difficult.
Atelocollagen Microspheres are produced only from atelocollagen, which can be completely removed (dissolved).

When a crude collagenase preparation (200 units/mg) containing various common hydrolytic enzymes used for cell dispersion was added to the microspheres to a final concentration of 0.1% and incubated at 37°C, the microspheres were completely dissolved after 60 min* (based on in-house data).


*Different types of collagenase are available on the market, and collagenase activity varies greatly. Therefore , the dissolution time varies depending on the collagenase used and its concentration.

 

Potential elimination of the need for microcarrier removal

The following paper showed that microspheres were dissolved by synovial fluid from patients with knee osteoarthritis, indicating the potential of microspheres to be administered directly as a transplant carrier after mass cultivation.

 

A novel cell source for therapy of knee osteoarthritis using atelocollagen microsphere-adhered adipose-derived stem cells: Impact of synovial fluid exposure on cell activity.

Sakamoto T, et al. Regen Ther. 2024 Apr 23;27:408-418. PMID: 38694445.

Adipose-derived mesenchymal stem cells were seeded onto the microspheres and cultured in a rotational system. In addition, the degradation of the microspheres by synovial fluid was evaluated.

 

Soluble microcarriers made from atelocollagen

https://stratus.campaign-image.com/images/730199000029656074_zc_v1_1746772827293_ipc50_255x200.jpg

Atelocollagen Microspheres 15mL/bottle

 

Seminar information

 

We plan to hold the following seminar in August 2025. We hope you will join us to take an opportunity to have the recent information on regenerative medicine, genome editing, and organoids.

 

Shin・Modality Seminar on regenerative medicine/cell therapy

 Date and time: Thursday, August 7, 2025, 1500–1700

 Venue: (1) Seminar room of Jikei University of Health Care Sciences, 15F, Future Medicine R&D Center, 

Nakanoshima Qross (up to 50 people)

   (2) Online (Broadcast through Teams Town Hall; up to 200 people)

 

 Presentation:

“Atelocollagen supporting the clinical application of regenerative medicine“ (Koken, Co., Ltd.)

“Cas9 protein gRNA complex (RNP) and prime editing that promote research and development of genome editing therapies” (GenScript Japan)

“Latest developments and applications of organoid culture technologies for various organs (primarily intestinal)”(Veritas Corporation)

 

 Details: Please click the following button for more details and application to the seminar (Japanese only)